Literature DB >> 16805609

Gold and gold-iron oxide magnetic glyconanoparticles: synthesis, characterization and magnetic properties.

Jesús M de la Fuente1, David Alcántara, Peter Eaton, Patricia Crespo, Teresa C Rojas, Asunción Fernandez, Antonio Hernando, Soledad Penadés.   

Abstract

The preparation, characterization and the magnetic properties of gold and gold-iron oxide glyconanoparticles (GNPs) are described. Glyconanoparticles were prepared in a single step procedure in the presence of aqueous solution of thiol functionalized neoglycoconjugates and either gold salts or both gold and iron salts. Neoglycoconjugates of lactose and maltose disaccharides with different linkers were used. Iron-free gold or gold-iron oxide GNPs with controlled gold-iron ratios were obtained. The average core-size diameters are in the range of 1.5-2.5 nm. The GNPs are fully characterized by (1)H NMR spectrometry, transmission electron microscopy (TEM), and UV-vis and X-ray absorption (XAS) spectroscopies. Inductive plasma-atomic emission spectrometry (ICP) and elemental analysis gave the average number of neoglycoconjugates per cluster. The magnetic properties were measured in a SQUID magnetometer. The most remarkable results was the observation of a permanent magnetism up to room temperature in the iron-free gold GNPs, that was not present in the corresponding gold-iron oxide GNPs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16805609     DOI: 10.1021/jp062522s

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  2 in total

Review 1.  Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine.

Authors:  João Conde; Jorge T Dias; Valeria Grazú; Maria Moros; Pedro V Baptista; Jesus M de la Fuente
Journal:  Front Chem       Date:  2014-07-15       Impact factor: 5.221

Review 2.  The glyconanoparticle as carrier for drug delivery.

Authors:  Xueqin Zhang; Gangliang Huang; Hualiang Huang
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.